Evidence map›Paper›PMID 24651673›Full record

ArticleScientific reports2014

Information content and analysis methods for multi-modal high-throughput biomedical data.

Bisakha Ray, Mikael Henaff, Sisi Ma, Efstratios Efstathiadis, Eric R Peskin, Marco Picone, Tito Poli, Constantin F Aliferis, Alexander Statnikov

Abstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. A mechanism-aware and multiomic machine-learning pipeline characterizes yeast cell growth.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Methods, Tools and Current Perspectives in Proteogenomics.Molecular & cellular proteomics : MCP · 2017
    Review
  8. Article
  9. Article
  10. Review
  11. Breast Cancer Prognostics Using Multi-Omics Data.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2016
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bisakha RayCenter for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA.
Mikael Henaff1] Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA [2] Department of Computer Science, New York University, NY, USA.
Sisi MaCenter for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA.
Efstratios EfstathiadisCenter for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA.
Eric R PeskinCenter for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA.
Marco Picone1] Department of Information Engineering, University of Parma, Parma, Italy [2] MultiMed Srl, Cremona, Italy.
Tito PoliMaxillofacial Surgery Section of the Head and Neck Department, University Hospital of Parma, Parma, Italy.
Constantin F Aliferis1] Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA [2] Department of Pathology, New York University School of Medicine, New York, NY, USA.
Alexander Statnikov1] Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY, USA [2] Department of Medicine, New York University School of Medicine, New York, NY, USA.

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR029893 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2011
$17.7M
Cancer Research UKNCRR NIH HHS 1UL1 RR029893NCRR NIH HHS UL1 RR029893
6 · The paper itself

Abstract

The spectrum of modern molecular high-throughput assaying includes diverse technologies such as microarray gene expression, miRNA expression, proteomics, DNA methylation, among many others. Now that these technologies have matured and become increasingly accessible, the next frontier is to collect "multi-modal" data for the same set of subjects and conduct integrative, multi-level analyses. While multi-modal data does contain distinct biological information that can be useful for answering complex biology questions, its value for predicting clinical phenotypes and contributions of each type of input remain unknown. We obtained 47 datasets/predictive tasks that in total span over 9 data modalities and executed analytic experiments for predicting various clinical phenotypes and outcomes. First, we analyzed each modality separately using uni-modal approaches based on several state-of-the-art supervised classification and feature selection methods. Then, we applied integrative multi-modal classification techniques. We have found that gene expression is the most predictively informative modality. Other modalities such as protein expression, miRNA expression, and DNA methylation also provide highly predictive results, which are often statistically comparable but not superior to gene expression data. Integrative multi-modal analyses generally do not increase predictive signal compared to gene expression data.

Indexed as

Computational BiologyDatasets as TopicDiagnostic ImagingDNA MethylationDNA, NeoplasmFemaleGene DosageGene ExpressionHumansMaleMicroRNAsNeoplasm ProteinsNeoplasmsPrognosisRNA, NeoplasmSurvival AnalysisDNA, NeoplasmMicroRNAsNeoplasm ProteinsRNA, Neoplasm

Identifiers

PMID24651673
PMCPMC3961740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.